In disease testing, patients and doctors are interested in estimates for positive predictive value (PPV) and negative predictive value (NPV). The PPV of a test is the probability that a patient actually has the disease, given a positive test result. The NPV is the probability that a patient actually does not have the disease, given a negative test result. Here we consider diagnostic tests in which the disease state remains uncertain, so the uncertain predictive value (UPV) is also of interest. UPV is the probability that, given an uncertain test result, follow-up testing will remain inconclusive. We derive classical Wald-type and Bayesian interval estimates of PPV, NPV, and UPV. Performance of these intervals is compared through simulation studies of interval coverage and width.
Introduction
The positive predictive value (PPV) and negative predictive value (NPV) of a diagnostic test are important to both patients and doctors. The PPV of a test is the probability that, given a positive test result, the patient actually has the disease. Similarly, the NPV of a test is the probability that, given a negative test result, the patient is actually disease-free. Mercaldo et al. (2007) derived Wald-type interval estimates of both PPV and NPV for binary diagnostic tests in case-control studies where the true disease prevalence is assumed known. Stamey and Holt (2010) derived analogous Bayesian interval estimates that allow for uncertainty relative to disease prevalence. Here we consider studies in which both the diagnostic test under consideration and the best test available may both provide inconclusive results, such as those and test result j. Likewise n i represents the total number of people in disease state i. Mercaldo et al. (2007) and Stamey and Holt (2010) described studies of this type that were not designed to reflect the true disease prevalence in the target population. The same situation is considered here.
Thus, we assume that these values are available from sources external to the current study and that p 1 represents the known population probability of disease and p 2 = 1 − p 1 reflects the known probability that a person is disease-free. 
The data in Table 1 
Mercaldo et al. (2007) derived Wald-type interval estimators for both PPV and NPV, based on equations (1) and (2). Likewise, Stamey and Holt (2010) derived analogous Bayesian estimators.
These will be discussed in Sections 2.2 and 2.3, respectively. Mercaldo et al. (2007) developed Wald-type interval estimators for PPV and NPV by employing the delta method to determine the variances of PPV and NPV. Assuming that the responses follow a binomial distribution and based on the asymptotic normality of the MLEs, the authors proposed an approximate interval for PPV of the form
Wald-Type Intervals
where is the (1-α/2) th quantile of the standard normal distribution and (Agresti and Caffo, 2000) . Here the adjusted estimates of Se and Sp became 
respectively. Mercaldo et al. (2007) compared the performance of these proposed interval methods, as well as intervals based on their logit transformations, using simulations of confidence interval width and coverage probability. They concluded that, when it provided a solution, the unadjusted logit transformation performed best. Otherwise, they recommended the adjusted standard interval. Stamey and Holt (2010) found, however, that the logit transformed solution often does not exist. Thus, the research herein focuses on adjusted standard Wald-type intervals.
Bayesian Intervals
Stamey and Holt (2010) derived Bayesian interval estimates of PPV and NPV for casecontrol studies described in Table 1 . Because such designs require a priori knowledge of disease prevalence, the authors considered two Bayesian models: one that took disease prevalence to be known and one that placed a prior distribution on prevalence.
Like Mercaldo et al. (2007) , Stamey and Holt (2010) assumed binomial data so that 
where
Taking p 1 and p 2 to be known, Monte Carlo sampling from the posteriors in (5) provided estimates of Se and Sp. Plugging these values into equations (1) and (2) yielded estimates of the posterior distribution for the unadjusted estimates of PPV and NPV. Adjusted estimates of PPV and NPV were similarly obtained, using equations (3) and (4).
The second model assumed that p 1 is in fact estimated from previous survey data or expert opinion. In this case, the value of p 1 in (1) and (2) The authors compared the interval width and true coverage probability of both Bayesian intervals to that of the adjusted standard interval and the unadjusted logit interval of Mercaldo et al. (2007) 
Multinomial Response Studies

Design
Now consider studies with the design described below in The data in Table 2 yield the following maximum likelihood estimators (MLE) of sensitivity (Se), specificity (Sp), and uncertainty (U): Using this design, we must also consider the probability of an uncertain test result among patients with the disease (Yu), the probability of an uncertain test result among patients without the disease (Nu), the probability of a positive test that cannot be confirmed or refuted by the gold standard (U 1 ), and the probability of a negative test that cannot be confirmed or refuted by the gold standard (U 2 ). These values are estimated by the following: Again we assume that p 1 represents the known population probability of disease; p 2 reflects the known probability that a person is disease-free; and p 3 is equal to the known probability of undeterminable results. Just as Mercaldo et al. (2007) and Stamey and Holt (2010) assumed a binomial distribution, we assume that 1
( , , ) x x x x = are independent and follow a multinomial distribution. Thus, the probability mass function for x 1 is ( ) 
We let t 1 = (Se, Fn, Yu), and write x 1 ~ M (n 1 , t 1 ). Similarly, t 2 = (Fp, Sp, Nu) and t 3 = (U 1 , U 2 , U) so that x 2 ~ M (n 2 , t 2 ), and x 3 ~ M (n 3 , t 3 ).
Applying Bayes Theorem produces the following estimators for PPV, NPV, and UPV:
Based on the equations (6) through (8), we extend the results of Mercaldo et al. (2007) and Stamey and Holt (2010) to situations in which both the diagnostic test being evaluated and the gold standard produce inconclusive results.
Wald-type Intervals
Consider first the estimation of the PPV. We derive a 100(1− α)% Wald-type interval by applying the delta method. The interval takes the form:
where is the (1-α/2) th quantile of the standard normal distribution. Because , , and Because x 1 , x 2 , and x 3 are independent, the covariances of , , and Se 
and the interval estimator ( )
As do Mercaldo et al. (2007) , we consider an Agresti type adjustment (2000) to improve performance of the estimators for proportions near 0 or 1. To do so, the data in Table 2 is adapted to become those presented below in Table 3 . . To our knowledge, however, no such recommendations exist for estimation of multinomial proportions.
Several values of k were considered and tested. We recommend k = 0.5 because it produced the best interval coverage and width in simulation-based performance analysis.
Bayesian Intervals
Next, we derive Bayesian estimators for PPV, NPV, and UPV. In the Bayesian model, we consider the Dirichlet distribution because it is the conjugate prior for multinomial data. Thus, the joint prior distribution for t 1 = (Se, Fn, Yu), the parameters in the distribution of x 1 , is ( 
Example
The research herein was motivated by the work of Khatami et al. (2007) . Khatami and co-authors developed a prediction model, combining the results of various blood and tissue markers, to determine whether or not a cancer originated in the ovaries. The model designated the cancer origin as ovaries, not ovaries, or uncertain. To determine its effectiveness, they compared its diagnoses against the standard histologic assessment. (Khatami et al., 2007) In order to calculate the interval estimates of PPV, NPV, and UPV, the values of p 1 , p 2 , and p 3 must be determined. We take these to be known but base them on calculations in Khatami et al. (2007) , we take p 1 to be 0.66. We take p 2 and p 3 to be 0.16 and 0.18, respectively. For the adjusted Wald-type interval, we take a = 0.5. For the Bayesian credible sets, t 1 , t 2 , and t 3 are each given noninformative Dirichlet (0.5, 0.5, 0.5) distributions. The resulting interval estimates are presented in Table 5 . Evaluating Table 5 , we see that the interval estimates are very similar. The main difference is in the different interpretations of a confidence interval and a credible set. A confidence interval states that there is a 95% chance that the true proportion is in the interval, while the credible set states that if we run the test an infinite number of times, 95% of the time the true proportion will be in the interval.
Conclusion
In this paper, we derive both Wald-type and Bayesian interval estimates of PPV, NPV, and UPV for diagnostic procedures with three possible outcomes. We considered prevalence to be known for both the Wald-type and Bayesian analysis. Both of these methods require knowledge of the outcome of the gold standard. Simulation studies indicate that the Bayesian approach using noninformative priors typically provides better coverage and smaller width than that of the Wald-type interval with a 0.5 Agresti type adjustment. It is, therefore, our conclusion that the Bayesian method is preferred. Future research will consider Bayesian analyses that incorporate informative Dirichlet priors to reflect any available prior information on values such as the sensitivity and specificity in order to further improve performance of the Bayesian method and Bayesian methods for estimating PPV, NPV, and UPV for unknown prevalence. Additional work will also expand the second model in Stamey and Holt (2010) to account for possible uncertainty about disease prevalence values.
